Torray LLC Bristol Myers Squibb CO Transaction History

Torray LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$0.13 - $76.84 $3,432 - $2.03 Million	-26,406 Reduced 14.08%	161,134 $11.5 Million
Q2 2022 Aug 03, 2022	SELL	$72.62 - $79.98 $2.12 Million - $2.34 Million	-29,231 Reduced 13.48%	187,540 $14.4 Million
Q1 2022 May 03, 2022	SELL	$61.48 - $73.72 $17,275 - $20,715	-281 Reduced 0.13%	216,771 $15.8 Million
Q4 2021 Feb 04, 2022	BUY	$53.63 - $62.52 $131,715 - $153,549	2,456 Added 1.14%	217,052 $13.5 Million
Q1 2021 May 03, 2021	BUY	$59.34 - $66.74 $2.96 Million - $3.33 Million	49,956 Added 30.34%	214,596 $13.5 Million
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $3,637 - $4,122	63 Added 0.04%	164,640 $10.2 Million
Q3 2020 Nov 02, 2020	SELL	$57.43 - $63.64 $173,266 - $192,001	-3,017 Reduced 1.8%	164,577 $9.92 Million
Q2 2020 Aug 03, 2020	SELL	$54.82 - $64.09 $9,922 - $11,600	-181 Reduced 0.11%	167,594 $9.86 Million
Q1 2020 Apr 28, 2020	BUY	$46.4 - $67.43 $7.78 Million - $11.3 Million	167,775 New	167,775 $9.35 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Torray LLC, based on Form 13F filings with the SEC.

Stay updated on Torray LLC with notifications on news.